Author details

Full Name

Lilin Lai

Affiliation

ORCID

Career Start Year

1992

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36725433	Cellular and humoral immunity to Ebola Zaire glycoprotein and viral vector proteins following immunization with recombinant vesicular stomatitis virus-based Ebola vaccine (rVSVÎ¿G-ZEBOV-GP).	Vaccine	2023
37808679	Comparative Analysis of SARS-CoV-2 Antigenicity across Assays and in Human and Animal Model Sera.	bioRxiv	2023
36951954	Durability of immune responses to mRNA booster vaccination against COVID-19.	J Clin Invest	2023
37191508	Efficacy of mRNA-1273 and Novavax ancestral or BA.1 spike booster vaccines against SARS-CoV-2 BA.5 infection in nonhuman primates.		2023
36622349	Low neutralizing activity of AZD7442 against current SARS-CoV-2 Omicron variants in patients with B-cell malignancies.		2023
36546661	Neutralization against BA.2.75.2, BQ.1.1, and XBB from mRNA Bivalent Booster.		2023
37167972	Molecular basis of SARS-CoV-2 Omicron variant evasion from shared neutralizing antibody response.		2023
37225997	Addendum: Systems vaccinology of the BNT162b2 mRNA vaccine in humans.	Nature	2023
35137154	Dose-Response of a Norovirus GII.2 Controlled Human Challenge Model Inoculum.	J Infect Dis	2022
35759727	Antibody Response to COVID-19 mRNA Vaccine in Patients With Lung Cancer After Primary Immunization and Booster: Reactivity to the SARS-CoV-2 WT Virus and Omicron Variant.	Journal of Clinical Oncology	2022
35436146	Humoral Responses Against SARS-CoV-2 and Variants of Concern After mRNA Vaccines in Patients With Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia.	Journal of Clinical Oncology	2022
35746552	Influenza Virus-like Particle-Based Hybrid Vaccine Containing RBD Induces Immunity against Influenza and SARS-CoV-2 Viruses.	Vaccines	2022
36273986	An Oil-in-Water adjuvant significantly increased influenza A/H7N9 split virus Vaccine-Induced circulating follicular helper T (cT) cells and antibody responses.	Vaccine	2022
35357886	A modified vaccinia Ankara vaccine expressing spike and nucleocapsid protects rhesus macaques against SARS-CoV-2 Delta infection.	Sci Immunol	2022
36324804	Molecular basis of SARS-CoV-2 Omicron variant evasion from shared neutralizing antibody response.		2022
35606518	Adjuvanting a subunit SARS-CoV-2 vaccine with clinically relevant adjuvants induces durable protection in mice.	NPJ Vaccines	2022
36380757	mRNA bivalent booster enhances neutralization against BA.2.75.2 and BQ.1.1.		2022
36644323	Antibody binding and neutralization of live SARS-CoV-2 variants including BA.4/5 following booster vaccination of patients with B-cell malignancies.		2022
36482977	Durability of immune responses to the booster mRNA vaccination against COVID-19.	medRxiv	2022
35233550	mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 omicron variant.	Cell Reports Medicine	2022
35018383	Antibody response to SARS-CoV-2 mRNA vaccine in lung cancer patients: Reactivity to vaccine antigen and variants of concern.		2022
35081298	SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination.	N Engl J Med	2022
34931200	Booster of mRNA-1273 Strengthens SARS-CoV-2 Omicron Neutralization.	medRxiv	2021
34075375	Evaluation of mRNA-1273 against SARS-CoV-2 B.1.351 Infection in Nonhuman Primates.		2021
34233096	Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants.	New England Journal of Medicine	2021
34013272	Infection and vaccine-induced neutralizing antibody responses to the SARS-CoV-2 B.1.617.1 variant.		2021
33907752	Immune Correlates of Protection by mRNA-1273 Immunization against SARS-CoV-2 Infection in Nonhuman Primates.	bioRxiv	2021
33798491	Infection- and vaccine-induced antibody binding and neutralization of the B.1.351 SARS-CoV-2 variant.		2021
34117252	SARS-CoV-2 RBD trimer protein adjuvanted with Alum-3M-052 protects from SARS-CoV-2 infection and immune pathology in the lung.	Nat Commun	2021
33688652	Vaccination with SARS-CoV-2 Spike Protein and AS03 Adjuvant Induces Rapid Anamnestic Antibodies in the Lung and Protects Against Virus Challenge in Nonhuman Primates.		2021
33631118	A modified vaccinia Ankara vector-based vaccine protects macaques from SARS-CoV-2 infection, immune pathology, and dysfunction in the lungs.	Immunity	2021
33952616	Evaluation of Cellular and Serological Responses to Acute SARS-CoV-2 Infection Demonstrates the Functional Importance of the Receptor-Binding Domain.	J Immunol	2021
33948610	Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells.	medRxiv	2021
34262052	Immunologic mechanisms of seasonal influenza vaccination administered by microneedle patch from a randomized phase I trial.	npj Vaccines	2021
33564782	Infection and mRNA-1273 vaccine antibodies neutralize SARS-CoV-2 UK variant.	medRxiv	2021
33873199	Adjuvanting a subunit COVID-19 vaccine to induce protective immunity.	Nature	2021
34252919	Systems vaccinology of the BNT162b2 mRNA vaccine in humans.	Nature	2021
34031659	Durability of mRNA-1273-induced antibodies against SARS-CoV-2 variants.	bioRxiv	2021
33822494	Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19.	New England Journal of Medicine	2021
33655254	Reduced binding and neutralization of infection- and vaccine-induced antibodies to the B.1.351 (South African) SARS-CoV-2 variant.		2021
34250512	Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and TÂ cells.	Cell Rep Med	2021
34315825	Protective antibodies elicited by SARS-CoV-2 spike protein vaccination are boosted in the lung after challenge in nonhuman primates.	Science Translational Medicine	2021
33594366	Adjuvanting a subunit SARS-CoV-2 nanoparticle vaccine to induce protective immunity in non-human primates.	bioRxiv	2021
33075363	Development and optimization of a Zika virus antibody-dependent cell-mediated cytotoxicity (ADCC) assay.	Journal of Immunological Methods	2021
34981056	mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 Omicron variant.		2021
34672695	Protection against SARS-CoV-2 Beta variant in mRNA-1273 vaccine-boosted nonhuman primates.	Science	2021
34449792	Original antigenic sin responses to Betacoronavirus spike proteins are observed in a mouse model, but are not apparent in children following SARS-CoV-2 infection.	PLoS ONE	2021
34426813	Protection against SARS-CoV-2 Beta Variant in mRNA-1273 Boosted Nonhuman Primates.	bioRxiv	2021
34529476	Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates.	Science	2021
34417590	mRNA-1273 protects against SARS-CoV-2 beta infection in nonhuman primates.	Nature Immunology	2021